Feb 02,2023

Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom

Mednow Inc. announced today the launch of its enhanced Virtual Diabetes Management program, an end-to-end digital diabetes management solution, to enable convenient on-demand access to Dexcom G6 real-time continuous glucose monitoring supplies and personalized diabetes care services. The Mednow clinical team will utilize the Dexcom Clarity data platform, to integrate individual glucose patterns and trends into personalized coaching and care.

COLLABORATION PARTNERSHIP

#institution

#cgm

#rpm

View Analyst & Ambassador Comments
Go to original news
Jan 31,2023

Cronometer x Dexcom integration revolutionizing digital health for People with Diabetes

Nutrition tracking app, Cronometer, will now integrate with Dexcom, the global leader in real-time continuous glucose monitoring (CGM). In the latest version of the Cronometer app, users residing in the U.S.A. will be able to import Dexcom CGM data and self-reported insulin data into their Cronometer accounts. The integration will allow Cronometer users to chart their glucose levels and insulin use over time. Cronometer Gold subscribers will also be able to use the Custom Charts feature to plot glucose or insulin data against specific nutrient intake, such as carbs, to help identify trends associated with their diet.

COLLABORATION PARTNERSHIP

#connected device

#mobile app

#cgm

View Analyst & Ambassador Comments
Go to original news
Feb 23,2023

Report: Apple moves forward with glucose monitoring tech

Apple reportedly believes it could shake up the CGM market with non-invasive glucose monitoring through the Apple Watch. Blooomberg reported that the company has a “moonshot-style” project in the works, according to “sources familiar with the matter.” The report said the tech giant still has years ahead in this development of the technology, which wouldn’t penetrate the skin. Bloomberg said Apple aims to use chip-based silicon photonics and optical absorption spectroscopy to measure glucose levels.

#cgm

View Analyst & Ambassador Comments
Go to original news
Feb 22,2023

New report points to rising out-of-pocket costs for people living with diabetes in Canada

Too many people living with diabetes in Canada are paying increasing costs for prescribed medications, devices, or supplies, according to Diabetes Canada’s new report on diabetes-related out-of-pocket costs. Living with diabetes in Canada continues to be marked by health inequity as out-of-pocket costs are especially acute for lower income groups and people affected by type 2 diabetes. In certain parts of Canada, out-of-pocket costs can be as high as $10,014 per year for people with type 2 diabetes. In certain parts of Canada, out-of-pocket costs can be as high as $18,306 per year for people with type 1 diabetes.

#insulin pump

#cgm

View Analyst & Ambassador Comments
Go to original news
Feb 22,2023

mylife Loop offers new remote monitoring feature for parents

Parents and caregivers of children with diabetes can now follow their child's glucose and insulin data via the mylife CamAPS FX app on their own personal smartphone. The new "Companion remote monitoring" feature is fully integrated into the app. It gives parents and caregivers better control and peace of mind. Especially at night, remote diabetes monitoring allows a relaxed sleep and can relieve caregivers considerably. Besides the common display of Continuous Glucose Monitoring (CGM) data, also insulin delivery data, Boost & Ease-Off usage, pump information and other relevant mylife CamAPS FX information can simply be shared with parents and caregivers. mylife YpsoPump and mylife CamAPS FX is the only automated insulin delivery (AID) system that can be connected either to the Dexcom G6 sensor from Dexcom or to the FreeStyle Libre 3 sensor from Abbott. Abbott's FreeStyle Libre 3 sensor has been compatible with mylife Loop in Germany since December 2022. This compatibility will be rolled out in Switzerland, UK and the Netherlands in the first half of 2023.

PRODUCT

#mobile app

#closed loop

#cgm

View Analyst & Ambassador Comments
Go to original news
Feb 22,2023

Dexcom Showcases Accuracy, Simplicity and Connectivity of Its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally

DexCom, Inc. will showcase the strength of its CGM portfolio and unveil new clinical and real-world evidence that continues to demonstrate the effectiveness of Dexcom CGM at the 16th International Conference on Advanced Technologies and Treatments for Diabetes held Feb. 22-25, 2023 in Berlin. Feedback from initial Dexcom G7 users has been positive, with consistent praise for the 60% smaller wearable, short warmup period on the market and more engaging and consumer-friendly mobile app. In addition, 97% of initial users surveyed found Dexcom G7 easy to use. The company also shared in the press release that from Spain to Estonia and the UK, more and more people living with diabetes are gaining access to real-time CGM as Dexcom ONE continues to launch in additional markets.

CONFERENCES

#cgm

View Analyst & Ambassador Comments
Go to original news
Feb 21,2023

Dexcom G6 Continuous Glucose Monitoring System Launches in Singapore

Dexcom, Inc. announced today the launch of its Dexcom G6 CGM System in Singapore for people with diabetes ages two years and older, including pregnant women, and the appointment of DKSH Singapore Pte Ltd as sales, marketing, and distribution service provider.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Feb 15,2023

Netherlands Diabetes Market Report 2023: Rising Prevalence of Obesity to Spur Future Growth - ResearchAndMarkets.com

Netherlands Diabetes Market will reach US$ 3.36 Billion in 2028 according to the publisher. The Netherlands Market is segmented into Self Monitoring Blood Glucose Device, Continuous Glucose Monitoring Devices, Insulin Pumps, and Insulin Pens. The prevalence of diabetes is increasing among all ages in the Netherlands, primarily due to increase in overweight and obesity, unhealthy diet, and physical inactivity.

#insulin pump

#insulin pen

#cgm

View Analyst & Ambassador Comments
Go to original news
Feb 13,2023

Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch

U.S. Centers for Medicare & Medicaid Services has approved coverage for Dexcom G7. Having met the category requirements for therapeutic CGM systems set forth by the U.S. Centers for Medicare & Medicaid Services, Dexcom G7 will be accessible to all Medicare patients with diabetes who meet the eligibility criteria when the system launches this Friday, Feb. 17.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Feb 13,2023

Glucose Biosensors Market to Worth US$ 46.16 Billion by 2033

The global glucose biosensors market is valued at US$ 14.09 billion in 2023 and is predicted to increase rapidly at a CAGR of 12.6% from 2023 to 2033, as per a new market analysis by Fact.MR, a market research and competitive intelligence provider. This high market growth can be attributed to aspects such as the rising prevalence of diabetes and the rapid adoption of improved glucose biosensor devices.

#bgm

#cgm

View Analyst & Ambassador Comments
Go to original news
Subscribe to CGM